Rex Health Ventures

410 Medical is a healthcare technology company based in Durham, North Carolina, founded in 2013. The company has developed an innovative rapid infuser device designed to facilitate the swift delivery of fluids to critically ill patients in need of volume resuscitation. This device enhances the speed and efficiency of fluid administration, significantly improving care for patients suffering from life-threatening conditions such as sepsis and shock. By enabling a single healthcare provider to quickly set up and deliver vital fluids, the solution minimizes provider fatigue and allows for simultaneous attention to other patient care needs. It is particularly beneficial in pre-hospital settings and emergency departments, where rapid response is essential and resources may be limited.

Arrivo BioVentures is a biopharmaceutical company based in Morrisville, North Carolina, founded in 2015. It develops biologics and small molecule therapies, including reformulated drugs and new chemical entities, to address patient needs. The company focuses on guiding drug candidates through development with strong regulatory strategies, coordinating early and frequent with the FDA and other authorities to expedite approval and minimize surprises. Its work includes designing efficient clinical programs and identifying regulatory pathways to shorten time to market, with the aim of improving patient outcomes.

Pryon is an artificial intelligence company specializing in enterprise knowledge management. Founded by Igor Jablokov in 2017, the company develops a natural language processing platform that transforms unstructured data into productive experiences, increasing efficiency with high accuracy and speed.

Founded in 2016, Emergo Therapeutics is a pharmaceutical company based in Durham, North Carolina. It specializes in developing drugs that modulate inflammatory cytokines to improve immune system functioning, with a focus on treating uncomplicated influenza and other infectious diseases.

TARGET PharmaSolutions, Inc. specializes in providing real-world data solutions tailored for drug development and commercialization. Founded in 2015 and headquartered in Durham, North Carolina, the company focuses on creating custom datasets and analyses to tackle complex healthcare evidence questions and quality initiatives. It offers a comprehensive health evidence solution that aggregates real-world data from a network of participating sites, in addition to providing bio specimen samples and consulting services. The company's foundation was inspired by the success of HCV-TARGET, a model established in 2011 that demonstrated the efficacy of real-world data in clinical research and regulatory processes. Through its innovative approaches, TARGET PharmaSolutions aims to enhance the drug development process and support evidence-based decision-making in healthcare.

Arrivo BioVentures is a biopharmaceutical company based in Morrisville, North Carolina, founded in 2015. It develops biologics and small molecule therapies, including reformulated drugs and new chemical entities, to address patient needs. The company focuses on guiding drug candidates through development with strong regulatory strategies, coordinating early and frequent with the FDA and other authorities to expedite approval and minimize surprises. Its work includes designing efficient clinical programs and identifying regulatory pathways to shorten time to market, with the aim of improving patient outcomes.

Baebies develops and manufactures innovative screening equipment for newborn babies. Its flagship product, SEEKER, is an FDA-authorized laboratory solution that simultaneously performs multiple assays using a single dried blood spot specimen. FINDER, another key product, enables near-patient testing in pediatric care. Baebies serves hospitals and public health labs worldwide.

Aerial BioPharma is a privately-held biopharmaceutical company based in Morrisville, North Carolina, near Research Triangle Park. Founded in 2011, the company specializes in developing biologics and small molecules targeted at conditions influenced by processes within the central nervous system. Aerial BioPharma's focus includes treatments for narcolepsy and other related conditions, aiming to provide advanced drug therapies for improved healthcare outcomes.